Controversies in the Management of Lymphomas

1. Front Matter

   Pages I-XIV

   PDF

2. The Lukes-Butler classification of Hodgkin’s disease revisited

   • James J. Butler

   Pages 1-18

3. Pitfalls in the diagnosis and classification of Hodgkin’s disease: Surgical pathology and classification for the 1980’s

   • Thomas V. Colby

   Pages 19-53

4. The Reed-Sternberg cell: Biological and clinical significance

   • Marshall E. Kadin

   Pages 55-90

5. Upon the enigma of Hodgkin’s disease and the Reed-Sternberg cell

   • Clive R. Taylor

   Pages 91-110

6. Selection of an imaging modality for staging abdominal involvement in the malignant lymphomas

   • Stephen I. Marglin, Ronald A. Castellino

   Pages 111-127

7. The definitive management of limited and intermediate stages of Hodgkin’s disease with radiation therapy alone

   • Richard T. Hoppe

   Pages 129-150

8. The role of combination chemotherapy alone or as an adjuvant to radiation therapy in limited stages of Hodgkin’s disease

   • Leonard R. Prosnitz

   Pages 151-166

9. Chemotherapy for stage III-A Hodgkin’s disease: The proper role

   • Richard S. Stein

   Pages 167-181

10. The Rappaport classification of the non-Hodgkin’s lymphomas: Is it pertinent for the 1980’s?

    • Bharat N. Nathwani

    Pages 183-224

11. Nodular mixed cell lymphoma: Is there a potential for a prolonged disease free survival and cure?

    • Tom Anderson

    Pages 225-238

12. Nodular mixed lymphoma: Failure to demonstrate prolonged disease free survival and cure

    • John H. Glick, Erica L. Orlow

    Pages 239-256

13. The role of treatment deferral in the management of patients with advanced, indolent non-Hodgkin’s lymphomas

    • Carol S. Portlock

    Pages 257-273

14. Early intervention with combined modality therapy for ‘favorable’ non-Hodgkin’s lymphomas of advanced stage

    • Timothy J. Kinsella

    Pages 275-291

15. Back Matter

    Pages 293-302

    PDF

Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good in­ depth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by dividing the oncology literature into specific subdivisions such as lung cancer, geni­ tourinary cancer, pediatric oncology, etc. Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more.

• Staging
• cancer treatment
• cell
• classification
• computed tomography (CT)
• imaging
• lymphoma
• pathology
• tumor

• Medical Oncology Division, Cancer Center of the University of Rochester Medical Center, Rochester, USA

  John M. Bennett

Policies and ethics